Data from a small US trial of the TOOKAD VTP system in low-risk disease

Earlier this year we reported data from a randomized, 400-patient trial in Europe of TOOKAD® Soluble vascular targeted photodynamic therapy (VTP) with the proprietary drug WST11. … READ MORE …